Actively Recruiting
Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
Led by Oulu University Hospital · Updated on 2026-04-07
534
Participants Needed
1
Research Sites
561 weeks
Total Duration
On this page
Sponsors
O
Oulu University Hospital
Lead Sponsor
U
University of Oulu
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to investigate the differences in microbiota, height and weight between infants born by cesarean section and randomized to receive fecal microbiota transplant after birth. The main questions it aims to answer are: * Could micobiota transplant be used improve gut microbiota and prevent overweight or obesity. * Is the source of colonization a modifiable factor and can it be changed by using an early fecal microbiota transplant.
CONDITIONS
Official Title
Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 18 to 49 years scheduled for elective cesarean section at term
- Recruitment occurs at 36 weeks of gestation during a delivery mode assessment visit at Oulu University Hospital, Finland
You will not qualify if you...
- Regular use of immunosuppressive biological medication
- Mother has inflammatory bowel disease
- Immunodeficiency disorder in mother or any first-degree family member of the unborn baby
- Known or suspected major fetal congenital abnormality
- Travel outside Europe, the United States, Canada, Japan, Australia, or New Zealand within the last three months
- Antibiotic treatment within three months of delivery (except prophylactic cefuroxime or alternative before elective cesarean section)
- Infant born preterm (before 37 weeks gestation)
- Infant birth weight below 2500 grams
- Infant admitted to neonatal intensive care unit
- Infant requires respiratory support or antibiotic treatment before discharge
- Suspected infection or abnormal newborn screening result for severe combined immunodeficiency (SCID)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oulu University Hospital
Oulu, Finland
Actively Recruiting
Research Team
M
Marika Paalanne, MD, PhD
CONTACT
T
Terhi Ruuska-Loewald, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here